Announcements Trials

Browse Landscape Eligibility

Clinical Trials

2 trials

Recent Start date Enrollment

Phase 4 × NSCLC × anlotinib × Clear all

Phase

Phase 2 3 Phase 4 2

Status

Sponsor Class

Study Type

Interventional 2

Sponsor

Cancer Type

Conditions

Small Cell Lung Carcinoma 2 NSCLC 2 Thyroid Neoplasms 1 Sarcoma 1 Proteinuria 1 Platinum-resistant Ovarian Cancer (PROC) 1 Advanced Thyroid Cancer Patients Who Received Target Therapy 1

Interventions

icotinib 2 anlotinib 2 Drug Therapy 2 lorlatinib 1 Thalidomide 1 Docetaxel 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05387109 2022-05-24

pcwaintrl

Tang-Du Hospital

Phase 4 Unknown

NSCLC

NCT03799601 2019-01-10

ALTER-L013

Tongji Hospital

Phase 4 Unknown

NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡